PL3501499T3 - Sposoby i kompozycje do wytwarzania aerozoli - Google Patents
Sposoby i kompozycje do wytwarzania aerozoliInfo
- Publication number
- PL3501499T3 PL3501499T3 PL19152522.9T PL19152522T PL3501499T3 PL 3501499 T3 PL3501499 T3 PL 3501499T3 PL 19152522 T PL19152522 T PL 19152522T PL 3501499 T3 PL3501499 T3 PL 3501499T3
- Authority
- PL
- Poland
- Prior art keywords
- aerosols
- compositions
- preparation
- methods
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30344710P | 2010-02-11 | 2010-02-11 | |
US201061426610P | 2010-12-23 | 2010-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL3501499T3 true PL3501499T3 (pl) | 2023-01-09 |
Family
ID=43899571
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11705486T PL2533761T3 (pl) | 2010-02-11 | 2011-02-11 | Sposoby i kompozycje do wytwarzania aerozoli |
PL19152522.9T PL3501499T3 (pl) | 2010-02-11 | 2011-02-11 | Sposoby i kompozycje do wytwarzania aerozoli |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11705486T PL2533761T3 (pl) | 2010-02-11 | 2011-02-11 | Sposoby i kompozycje do wytwarzania aerozoli |
Country Status (17)
Country | Link |
---|---|
US (3) | US9713589B2 (pl) |
EP (2) | EP2533761B1 (pl) |
JP (3) | JP5951508B2 (pl) |
CN (2) | CN105380904A (pl) |
AU (1) | AU2011214299B2 (pl) |
CA (1) | CA2787718C (pl) |
CY (1) | CY1122634T1 (pl) |
DK (1) | DK2533761T3 (pl) |
ES (2) | ES2931330T3 (pl) |
HK (1) | HK1222128A1 (pl) |
HR (1) | HRP20191071T1 (pl) |
HU (1) | HUE044292T2 (pl) |
LT (1) | LT2533761T (pl) |
PL (2) | PL2533761T3 (pl) |
PT (2) | PT3501499T (pl) |
SI (1) | SI2533761T1 (pl) |
WO (1) | WO2011098552A2 (pl) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3004707C (en) | 2009-09-02 | 2022-05-31 | Synedgen Inc. | Methods and compositions for disrupting biofilm utilizing chitosan-derivative compounds |
PL2533761T3 (pl) | 2010-02-11 | 2019-09-30 | Ablynx N.V. | Sposoby i kompozycje do wytwarzania aerozoli |
SG10201501872XA (en) | 2010-03-12 | 2015-05-28 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
PE20180414A1 (es) * | 2011-06-17 | 2018-03-01 | Berg Llc | Composiciones farmaceuticas inhalables |
WO2014045213A1 (en) * | 2012-09-18 | 2014-03-27 | Adocia | Stable pharmaceutical composition, comprising an aqueous solution of an antibody-derived therapeutically active protein |
CN117679487A (zh) | 2013-03-15 | 2024-03-12 | 得克萨斯州大学系统董事会 | 用Nutlin-3a和肽抑制肺纤维化 |
NL1040254C2 (en) * | 2013-05-17 | 2014-11-24 | Ablynx Nv | Stable formulations of immunoglobulin single variable domains and uses thereof. |
AU2015239145B2 (en) * | 2014-04-03 | 2019-07-11 | Csl Behring Ag | Nebulization of immunoglobulin |
EP3190886B1 (en) * | 2014-09-11 | 2024-04-10 | Synedgen, Inc. | Compositions for use in the treatment of acute respiratory distress syndrome |
CN106999420B (zh) * | 2014-10-10 | 2021-08-10 | 埃博灵克斯股份有限公司 | 用于呼吸系统疾病的气溶胶疗法的吸入装置 |
US10561805B2 (en) | 2014-10-10 | 2020-02-18 | Ablynx N.V. | Methods of treating RSV infections |
BR112017018209A2 (pt) * | 2015-02-27 | 2018-04-17 | Board Of Regents, The University Of Texas System | produtos terapêuticos de polipeptídeo e usos dos mesmos |
US20190127447A1 (en) | 2016-05-02 | 2019-05-02 | Ablynx N.V. | Treatment of rsv infection |
WO2018099968A1 (en) | 2016-11-29 | 2018-06-07 | Ablynx N.V. | Treatment of infection by respiratory syncytial virus (rsv) |
AU2018277343A1 (en) | 2017-06-02 | 2020-01-02 | Ablynx N.V. | Adamts binding immunoglobulins |
AU2019339260A1 (en) | 2018-09-10 | 2021-03-25 | Lung Therapeutics, Inc. | Modified peptide fragments of Cav-1 protein and the use thereof in the treatment of fibrosis |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2919890B2 (ja) | 1988-11-11 | 1999-07-19 | メディカル リサーチ カウンスル | 単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用 |
US5945098A (en) * | 1990-02-01 | 1999-08-31 | Baxter International Inc. | Stable intravenously-administrable immune globulin preparation |
US5938117A (en) | 1991-04-24 | 1999-08-17 | Aerogen, Inc. | Methods and apparatus for dispensing liquids as an atomized spray |
PT1498427E (pt) | 1992-08-21 | 2010-03-22 | Univ Bruxelles | Imunoglobulinas desprovidas de cadeias leves |
DK0698097T3 (da) | 1993-04-29 | 2001-10-08 | Unilever Nv | Produktion af antistoffer eller (funktionaliserede) fragmenter deraf afledt af Camelidae-immunoglobuliner med tung kæde |
FR2708622B1 (fr) | 1993-08-02 | 1997-04-18 | Raymond Hamers | Vecteur recombinant contenant une séquence d'un gène de lipoprotéine de structure pour l'expression de séquences de nucléotides. |
US5586550A (en) | 1995-08-31 | 1996-12-24 | Fluid Propulsion Technologies, Inc. | Apparatus and methods for the delivery of therapeutic liquids to the respiratory system |
US6085740A (en) | 1996-02-21 | 2000-07-11 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
US6014970A (en) | 1998-06-11 | 2000-01-18 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US6205999B1 (en) | 1995-04-05 | 2001-03-27 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
US5758637A (en) | 1995-08-31 | 1998-06-02 | Aerogen, Inc. | Liquid dispensing apparatus and methods |
EP0739981A1 (en) | 1995-04-25 | 1996-10-30 | Vrije Universiteit Brussel | Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes |
CA2258518C (en) | 1996-06-27 | 2011-11-22 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Recognition molecules interacting specifically with the active site or cleft of a target molecule |
ATE461282T1 (de) | 1997-10-27 | 2010-04-15 | Bac Ip Bv | Multivalente antigenbindende proteine |
BR9907241A (pt) | 1998-01-26 | 2000-10-17 | Unilever Nv | Biblioteca de expressão, processo para preparar a mesma, uso de uma fonte não imunizada de sequências de ácido nucleico, e, processos para preparar fragmentos de anticorpos e, para preparar um anticorpo |
WO2000040968A1 (en) | 1999-01-05 | 2000-07-13 | Unilever Plc | Binding of antibody fragments to solid supports |
WO2000043507A1 (en) | 1999-01-19 | 2000-07-27 | Unilever Plc | Method for producing antibody fragments |
CN100434441C (zh) | 1999-04-22 | 2008-11-19 | 荷兰联合利华有限公司 | 利用单价抗原-结合蛋白抑制病毒感染 |
US6479280B1 (en) | 1999-09-24 | 2002-11-12 | Vlaams Interuniversitair Institutuut Voor Biotechnologie Vzw | Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
EP1242460B1 (en) | 1999-11-29 | 2006-10-18 | Unilever Plc | Immobilisation of proteins using a polypeptide segment |
ATE440111T1 (de) | 1999-11-29 | 2009-09-15 | Bac Ip B V | Immobilisierte antigenbindende moleküle aus einer domäne |
ATE428733T1 (de) | 2000-03-14 | 2009-05-15 | Unilever Nv | Variabele domänen der schweren kette eines antikörpers gegen menschliche ernährungslipasen und deren verwendungen |
CA2380443C (en) | 2000-05-26 | 2013-03-12 | Ginette Dubuc | Single-domain antigen-binding antibody fragments derived from llama antibodies |
WO2002048193A2 (en) | 2000-12-13 | 2002-06-20 | Unilever N.V. | Camelidae antibody arrays |
US20060073141A1 (en) | 2001-06-28 | 2006-04-06 | Domantis Limited | Compositions and methods for treating inflammatory disorders |
US7371849B2 (en) | 2001-09-13 | 2008-05-13 | Institute For Antibodies Co., Ltd. | Methods of constructing camel antibody libraries |
JP2005289809A (ja) | 2001-10-24 | 2005-10-20 | Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) | 突然変異重鎖抗体 |
AU2002351896A1 (en) | 2001-12-11 | 2003-06-23 | Ablynx N.V. | Method for displaying loops from immunoglobulin domains in different contexts |
US20050037358A1 (en) | 2001-12-21 | 2005-02-17 | Serge Muyldermans | Method for cloning of variable domain sequences |
CA2471645A1 (en) | 2002-01-03 | 2003-07-10 | Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw | Immunoconjugates useful for treatment of tumours |
US20050271660A1 (en) | 2002-09-06 | 2005-12-08 | Alexion Pharmaceuticals, Inc. | Nebulization of monoclonal antibodies for treating pulmonary diseases |
US20060228355A1 (en) | 2003-11-07 | 2006-10-12 | Toon Laeremans | Camelidae single domain antibodies vhh directed against epidermal growth factor receptor and uses therefor |
EP2267032A3 (en) | 2002-11-08 | 2011-11-09 | Ablynx N.V. | Method of administering therapeutic polypeptides, and polypeptides therefor |
EP1900753B1 (en) | 2002-11-08 | 2017-08-09 | Ablynx N.V. | Method of administering therapeutic polypeptides, and polypeptides therefor |
CA2512545C (en) | 2003-01-10 | 2015-06-30 | Karen Silence | Recombinant vhh single domain antibody from camelidae against von willebrand factor (vwf) |
US7461263B2 (en) | 2003-01-23 | 2008-12-02 | Unspam, Llc. | Method and apparatus for a non-revealing do-not-contact list system |
JP2007521234A (ja) | 2003-08-12 | 2007-08-02 | ウィリアム エム ヤーブロー | 尋常性ざ瘡の治療薬及び使用方法 |
US7563443B2 (en) | 2004-09-17 | 2009-07-21 | Domantis Limited | Monovalent anti-CD40L antibody polypeptides and compositions thereof |
EP1814917A2 (en) | 2004-10-13 | 2007-08-08 | Ablynx N.V. | Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease |
JP2008528010A (ja) | 2005-01-31 | 2008-07-31 | アブリンクス ナームローゼ フェンノートシャップ | 重鎖抗体の可変ドメイン配列を作出する方法 |
EP2949668B1 (en) | 2005-05-18 | 2019-08-14 | Ablynx N.V. | Improved nanobodies tm against tumor necrosis factor-alpha |
CA2608873C (en) | 2005-05-20 | 2017-04-25 | Ablynx Nv | Single domain vhh antibodies against von willebrand factor |
JP2009523459A (ja) * | 2006-01-24 | 2009-06-25 | ドマンティス リミテッド | 天然の連結部を含有する融合タンパク質 |
EP2004690A2 (en) | 2006-03-13 | 2008-12-24 | Ablynx N.V. | Amino acid sequences directed against il-6 and polypeptides comprising the same for the treatment of diseases and disorders associated with il-6-mediated signalling |
WO2008020079A1 (en) | 2006-08-18 | 2008-02-21 | Ablynx N.V. | Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of deseases and disorders associated with il-6-mediated signalling |
EP2069402A2 (en) | 2006-09-08 | 2009-06-17 | Ablynx N.V. | Serum albumin binding proteins with long half-lives |
CA2667466A1 (en) * | 2006-10-27 | 2008-05-02 | Ablynx N.V. | Intranasal delivery of polypeptides and proteins |
WO2008071447A2 (en) | 2006-12-15 | 2008-06-19 | Ablynx N.V. | Amino acid sequences that modulate the interaction between cells of the immune system |
EP2514767A1 (en) | 2006-12-19 | 2012-10-24 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders |
WO2008074839A2 (en) | 2006-12-19 | 2008-06-26 | Ablynx N.V. | Amino acid sequences directed against gpcrs and polypeptides comprising the same for the treatment of gpcr-related diseases and disorders |
US20100166734A1 (en) | 2006-12-20 | 2010-07-01 | Edward Dolk | Oral delivery of polypeptides |
EP2097451A2 (en) | 2006-12-22 | 2009-09-09 | Ablynx N.V. | Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies |
CL2008000058A1 (es) * | 2007-01-09 | 2008-05-23 | Wyeth Corp | Formulacion que comprende un anticuerpo anti-il13, un criprotector, y una solucion amortiguadora; composicion farmaceutica que la comprende; metodo para tratar un trastorno relacionado con il13; y formas farmaceuticas que la comprenden. |
US20110118185A9 (en) | 2007-02-21 | 2011-05-19 | Ablynx N.V. | Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
RU2481355C2 (ru) | 2007-05-24 | 2013-05-10 | Аблинкс Н.В. | Аминокислотные последовательности, направленные на rank-l, и полипептиды, включающие их, для лечения заболеваний и нарушений костей |
WO2008142165A1 (en) | 2007-05-24 | 2008-11-27 | Ablynx N.V. | Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors |
JP2011504740A (ja) | 2007-11-27 | 2011-02-17 | アブリンクス エン.ヴェー. | ヘテロ二量体サイトカイン及び/又はこれらの受容体に指向性を有するアミノ酸配列、並びにこれを含むポリペプチド |
AU2008334605B2 (en) | 2007-12-13 | 2013-07-18 | Glaxo Group Limited | Polypeptides, antibody variable domains & antagonists |
CA2726652A1 (en) | 2008-06-05 | 2009-12-10 | Ablynx N.V. | Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases |
US8945567B2 (en) | 2009-06-05 | 2015-02-03 | Ablynx N.V. | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (HRSV) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
US9884117B2 (en) | 2009-09-03 | 2018-02-06 | Ablynx N.V. | Stable formulations of polypeptides and uses thereof |
PL2533761T3 (pl) | 2010-02-11 | 2019-09-30 | Ablynx N.V. | Sposoby i kompozycje do wytwarzania aerozoli |
-
2011
- 2011-02-11 PL PL11705486T patent/PL2533761T3/pl unknown
- 2011-02-11 ES ES19152522T patent/ES2931330T3/es active Active
- 2011-02-11 PT PT191525229T patent/PT3501499T/pt unknown
- 2011-02-11 PT PT11705486T patent/PT2533761T/pt unknown
- 2011-02-11 EP EP11705486.6A patent/EP2533761B1/en active Active
- 2011-02-11 US US13/577,961 patent/US9713589B2/en active Active
- 2011-02-11 JP JP2012552404A patent/JP5951508B2/ja active Active
- 2011-02-11 CN CN201510824525.1A patent/CN105380904A/zh active Pending
- 2011-02-11 AU AU2011214299A patent/AU2011214299B2/en active Active
- 2011-02-11 LT LTEP11705486.6T patent/LT2533761T/lt unknown
- 2011-02-11 HU HUE11705486 patent/HUE044292T2/hu unknown
- 2011-02-11 DK DK11705486.6T patent/DK2533761T3/da active
- 2011-02-11 CN CN201180009097.7A patent/CN102753148B/zh active Active
- 2011-02-11 EP EP19152522.9A patent/EP3501499B1/en active Active
- 2011-02-11 PL PL19152522.9T patent/PL3501499T3/pl unknown
- 2011-02-11 CA CA2787718A patent/CA2787718C/en active Active
- 2011-02-11 WO PCT/EP2011/052024 patent/WO2011098552A2/en active Application Filing
- 2011-02-11 SI SI201131740T patent/SI2533761T1/sl unknown
- 2011-02-11 ES ES11705486T patent/ES2738114T3/es active Active
-
2016
- 2016-06-08 JP JP2016114294A patent/JP6283064B2/ja active Active
- 2016-08-31 HK HK16110367.6A patent/HK1222128A1/zh unknown
-
2017
- 2017-04-24 US US15/495,199 patent/US11007146B2/en active Active
-
2018
- 2018-01-25 JP JP2018010149A patent/JP7019433B2/ja active Active
-
2019
- 2019-06-13 HR HRP20191071TT patent/HRP20191071T1/hr unknown
- 2019-06-26 CY CY20191100668T patent/CY1122634T1/el unknown
-
2021
- 2021-04-19 US US17/233,621 patent/US20210346287A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222128A1 (zh) | 用於製備氣霧劑的方法和組合物 | |
IL263729A (en) | Preparations and methods for removing biofilms | |
HK1202071A1 (en) | Biocidal compositions and methods of using the same | |
HK1185796A1 (zh) | 包含近端支化化合物的組合物及其製備方法 | |
ZA201402734B (en) | Collector compositions and methods of using the same | |
EP2536756A4 (en) | HSA-RELATED COMPOSITIONS AND USE PROCESSES | |
EP2584897A4 (en) | COMPOSITIONS CONTAINING RESVERATROL AND METHODS OF USE | |
EP2569425A4 (en) | ENDORIBONUCLEASE COMPOSITIONS AND METHOD FOR THEIR USE | |
GB2507210B (en) | Insecticidal compositions and methods of using the same | |
IL222969A0 (en) | Sweetener compositions and methods of preparing the same | |
EP2596112A4 (en) | ACETYCYSTEIN COMPOSITIONS AND USE METHOD THEREFOR | |
EP2582664A4 (en) | PHENYL THIOACETATE COMPOUNDS AND COMPOSITIONS AND METHOD FOR THEIR USE | |
EP2552202A4 (en) | METHODS AND COMPOSITIONS FOR WEIGHT LOSS | |
EP2629742A4 (en) | HAIR CARE COMPOSITIONS AND RELATED METHODS | |
EP2539444A4 (en) | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF L-HOMOALANINE | |
HK1189501A1 (zh) | 抗體組合物及使用方法 | |
EP2633047A4 (en) | COMPOSITIONS AND METHOD FOR PRODUCING BLOOD PLATES AND USE METHOD THEREFOR | |
HK1201451A1 (en) | Compositions and methods | |
GB201018650D0 (en) | Methods and compositions | |
HK1254904B (zh) | 用於改變xlhed表型的組合物和方法 | |
IL226174A0 (en) | Impulse preparations and methods for their preparation | |
GB201020357D0 (en) | Compounds and methods of making the same | |
GB201002278D0 (en) | composition and method of preparation | |
ZA201209495B (en) | Novel methods for the preparation of p2x7r antagonists | |
HU1000329D0 (en) | Nanostuctured ibuprofene compositions and process for their preparation |